Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07225777

Sex Differences in Neurobehavioral Response to THC

Sex Differences in Neurobehavioral Response to Acute THC in Adults With Cannabis Use Disorder

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study investigates sex differences in reward processing following acute THC administration in adults with cannabis use disorder (CUD). Using multimodal neuroimaging (MRS and fMRI), the study will assess glutamate levels in the nucleus accumbens and striatal BOLD response to monetary reward anticipation. Participants will complete two counterbalanced dosing sessions (oral THC 40 mg vs. placebo).

Conditions

Interventions

TypeNameDescription
DRUGDronabinolOral dronabinol capsules (40 mg)
DRUGPlaceboMatched placebo capsules

Timeline

Start date
2026-05-01
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2025-11-10
Last updated
2026-04-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07225777. Inclusion in this directory is not an endorsement.

Sex Differences in Neurobehavioral Response to THC (NCT07225777) · Clinical Trials Directory